首页> 美国卫生研究院文献>OncoTargets and therapy >Lymphangioleiomyomatosis: a case report and review of diagnosis and treatment
【2h】

Lymphangioleiomyomatosis: a case report and review of diagnosis and treatment

机译:淋巴管平滑肌肌瘤病:1例病例报告及诊治回顾

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lymphangioleiomyomatosis (LAM) is a rare disease that generally affects young women and involves the abnormal proliferation of smooth muscle-like cells (LAM cells) in the lungs (pulmonary LAM) and extrapulmonary sites (extrapulmonary LAM). This disease is rare in males. It is hard to distinguish between lung cancer and pulmonary LAM, especially during early stages. Herein, we present a case of a 66-year-old man with a small nodule in the right upper lobe that was first diagnosed as a lung malignancy using a chest CT scan. After a wedge dissection, a pathologist performed a histologic and immunohistochemical examination, and a diagnosis of pulmonary LAM was made. We further performed a 518-gene panel analysis using next-generation sequencing, and only three genes, BARD1, BLM, and BRCA2, were found to have mutations. We also provide a summary of the diagnosis and treatment of this disease.
机译:淋巴管平滑肌肌瘤病(LAM)是一种罕见的疾病,通常会影响年轻女性,涉及肺(肺LAM)和肺外部位(肺外LAM)平滑肌样细胞(LAM细胞)的异常增殖。这种病在男性中很少见。很难区分肺癌和肺LAM,尤其是在早期阶段。本文中,我们介绍了一个66岁的男性右上叶有一个小结节的病例,该病例首先通过胸部CT扫描被诊断为肺恶性肿瘤。楔形解剖后,病理学家进行了组织学和免疫组化检查,并诊断出肺LAM。我们进一步使用下一代测序技术进行了518个基因的小组分析,结果发现只有三个基因BARD1,BLM和BRCA2存在突变。我们还提供了该疾病的诊断和治疗的摘要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号